Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Premature Ovarian Failure
ChiCTR2100050641Phase 2Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sirolimus in ovarian hypofunction (POI), sponsored by Peking Union Medical College Hospital. Primary endpoints: anti-mullerian hormone at 6 months and sex hormones (6 items) at 6 months. Started Oct 2021; status: recruiting.
02
Drugs
sirolimus
03
Conditions
ovarian hypofunction (POI)
Beyond the preview
Go deeper on ChiCTR2100050641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050641.